ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ERGO Ergomed Plc

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% - 0.00 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ergomed Share Discussion Threads

Showing 1001 to 1020 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
14/4/2023
02:01
Steady support from Octopus ...
piedro
26/3/2023
18:23
Yep Piedro, very impressive contribution - great graph!
maddox
25/3/2023
10:55
This is a chart I like that illustrates the Barfield era ...
piedro
22/3/2023
23:49
Thanks Piedro,

What your graph nicely illustrates is the growing revenue from North America. They have now established sufficient scale to compete for top-tier contracts - if successful this will further propel growth over the next few years.

maddox
21/3/2023
11:19
No Dividend but excellent results and in-line with analyst consensus forecasts:

Service fee revenue +24% (in-line with analyst consensus forecasts)
Gross profit +22%
Gross margin +40.7%
Adj. EBITDA +11.5%
Adj. eps 42.6p (consensus 40.1p)
Order book +23%

ADAMAS acquisition looks to have bedded-in well and the outlook looks highly positive.
So, we have a strongly growing company in a growing market - but growing ahead of that market growth.

Postscript: Shares opened at 1020p rose 40p to 1060p but then faltered and dropped down 23p at 997p. interesting reaction to strong results indicative of a risk-off market rather than specific to ERGO.

maddox
29/1/2023
11:03
Richard Barfield has been extremely impressive so very grateful for his contribution to the transformation of ERGO. He will be a difficult act to follow. However, the strategy is set and the execution going exceedingly well so his contribution will be sustained.

He has a c. 1m options on shares which is equivalent to about 2% of ERGO, so we'll have to see what he does with these. Hopefully he'll retain a sizeable holding in ERGO and an informal, if not formal, advisory role in future.

Apart from that I like to express my thanks as a shareholder and wish him a very long and very, very happy retirement. If you share my sentiments please give this post a thumbs-up.

Cheers Maddox

maddox
27/1/2023
10:19
better he retired then jumped ship to another company. IMHO.
mfhmfh
26/1/2023
16:00
"Richard Barfield retiring is a big negative ..."

LOL, no doubt conspiracy theories abound

"he sold a large part of his shareholding last year - I took his cue and sold out then"

So what?. He cashed in 125,000 10p options and has plenty more

piedro
26/1/2023
15:11
RB's retirement a very big negative sign. he sold a large part of his shareholding last year - I took his cue and sold out then
qvg
26/1/2023
12:28
Richard Barfield retiring is a big negative on the stock unfortunately. In short he transformed his previous company and then Ergomed - check the share price after he was appointed .The retirement expectation was on the wall when the deputy CFO was appointed. I sold half before the announcement and the other half yesterday.
ihatemms
26/1/2023
10:56
Positive trading update.

But no move in share price. Likely due to the still high PE ratio in an era where PEs have reduced a lot.

fegger
14/10/2022
16:34
Octopus holdings {from my records}
piedro
10/10/2022
12:06
PrimeVigilance@PrimeVigilance
EVENT – Greetings from Tokyo! We are so pleased to be a first-time exhibitor
at the DIA Japan Annual Meeting.
If you are attending, look up Booth #19 and stop by to meet our team from our
regional hub in Tokyo.

piedro
27/9/2022
17:06
It is a service business
Productivity improvements are probably limited

phillis
27/9/2022
13:19
Updated chart ...



- that is what I wanted to see: cost growth moderated

piedro
27/9/2022
10:46
Another very impressive web-cast today.
ihatemms
26/7/2022
12:32
Ergomed cheers 'very strong' performance in first half of 2022
piedro
26/7/2022
10:54
Excellent update for interims and H2 outlook particularly order book. glad I topped up recently.
adorling
26/7/2022
10:47
Business as usual update,
but can they keep costs under control?

piedro
25/7/2022
12:22
let's see what tomorrow brings
mfhmfh
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older

Your Recent History

Delayed Upgrade Clock